Aeterna Zentaris
AEZS
#10198
Rank
S$22.71 M
Marketcap
S$7.42
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

EPS for Aeterna Zentaris (AEZS)

EPS in 2024 (TTM): S-$2.77

According to Aeterna Zentaris's latest financial reports the company's current EPS (TTM) is S-$2.66. In 2022 the company made an earnings per share (EPS) of S-$6.07 a decrease over its 2021 EPS that were of S-$2.36.

EPS history for Aeterna Zentaris from 1998 to 2024

Annual EPS

Year EPS Change
2024 (TTM)S-$2.77
2022S-$6.07157.14%
2021S-$2.36-41.48%
2020S-$4.03-64.46%
2019S-$11.35-240%
2018S$8.11-122.32%
2017S-$36.32-53.53%
2016S-$78.16-86.71%
2015S-$588.33-35.21%
2014S-$908.11-216.67%
2013S$778.38-123.3%
2012S-$3,341-40.8%
2011S-$5,643-6.45%
2010S-$6,032-27.91%
2009S-$8,368-61.61%
2008S-$21,79583.61%
2007S-$11,870-195.31%
2006S$12,454178.26%
2005S$4,476-330%
2004S-$1,946-80.05%
2003S-$9,75417.78%
2002S-$8,282515.93%
2001S-$1,345-68.6%
2000S-$4,283119.62%
1999S-$1,950-3.63%
1998S-$2,023

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Spectrum Pharmaceuticals
SPPI
S-$0.47-82.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$9.55-459.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Bristol-Myers Squibb
BMY
S$3.85-244.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$4.81-280.86%๐Ÿ‡ซ๐Ÿ‡ท France
Halozyme Therapeutics
HALO
S$6.34-338.66%๐Ÿ‡บ๐Ÿ‡ธ USA